FDA panel split on Sanofi-Lexicon diabetes drug

A U.S. FDA advisory panel to the voted 8-8 over whether to recommend approval of a treatment for type 1 diabetes developed by Sanofi and Lexicon Pharmaceuticals.
Source: PharmaManufacturing.com - Category: Pharmaceuticals Source Type: news